165 related articles for article (PubMed ID: 31754084)
1. p62-DNA-encoding plasmid reverts tumor grade, changes tumor stroma, and enhances anticancer immunity.
Venanzi FM; Gabai V; Mariotti F; Magi GE; Vullo C; Sufianov AA; Kolesnikov SI; Shneider A
Aging (Albany NY); 2019 Nov; 11(22):10711-10722. PubMed ID: 31754084
[TBL] [Abstract][Full Text] [Related]
2. Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector.
Venanzi F; Shifrin V; Sherman M; Gabai V; Kiselev O; Komissarov A; Grudinin M; Shartukova M; Romanovskaya-Romanko EA; Kudryavets Y; Bezdenezhnykh N; Lykhova O; Semesyuk N; Concetti A; Tsyb A; Filimonova M; Makarchuk V; Yakubovsky R; Chursov A; Shcherbinina V; Shneider A
Oncotarget; 2013 Oct; 4(10):1829-35. PubMed ID: 24121124
[TBL] [Abstract][Full Text] [Related]
3. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor effects of pNEgr-mIL-12 recombinant plasmid induced by X-irradiation and its mechanisms.
Yang Y; Liu SZ; Fu SB
Biomed Environ Sci; 2004 Jun; 17(2):135-43. PubMed ID: 15386939
[TBL] [Abstract][Full Text] [Related]
5. Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice.
Heinzerling L; Dummer R; Pavlovic J; Schultz J; Burg G; Moelling K
Exp Dermatol; 2002 Jun; 11(3):232-40. PubMed ID: 12102662
[TBL] [Abstract][Full Text] [Related]
6. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma.
Lucas ML; Heller L; Coppola D; Heller R
Mol Ther; 2002 Jun; 5(6):668-75. PubMed ID: 12027550
[TBL] [Abstract][Full Text] [Related]
7. Electrogenetherapy of B16.F10 murine melanoma tumors with an interleukin-28 expressing DNA plasmid.
Shah K; Connolly RJ; Chapman T; Jaroszeski MJ; Ugen KE
Hum Vaccin Immunother; 2012 Nov; 8(11):1722-8. PubMed ID: 23151446
[TBL] [Abstract][Full Text] [Related]
8. p62/SQSTM1 indirectly mediates remote multipotent mesenchymal cells and rescues bone loss and bone marrow integrity in ovariectomized rats.
Agas D; Marchegiani A; Laus F; Gabai V; Sufianov AA; Shneider A; Sabbieti MG
J Cell Physiol; 2023 Feb; 238(2):407-419. PubMed ID: 36565474
[TBL] [Abstract][Full Text] [Related]
9. p62/SQSTM1 expression in canine mammary tumours: Evolutionary notes.
Mariotti F; Magi GE; Gavazza A; Vincenzetti S; Komissarov A; Shneider A; Venanzi FM
Vet Comp Oncol; 2019 Dec; 17(4):570-577. PubMed ID: 31332942
[TBL] [Abstract][Full Text] [Related]
10. Electromobility of plasmid DNA in tumor tissues during electric field-mediated gene delivery.
Zaharoff DA; Barr RC; Li CY; Yuan F
Gene Ther; 2002 Oct; 9(19):1286-90. PubMed ID: 12224011
[TBL] [Abstract][Full Text] [Related]
11. Antitumor vaccination by Newcastle Disease Virus Hemagglutinin-Neuraminidase plasmid DNA application: changes in tumor microenvironment and activation of innate anti-tumor immunity.
Ni J; Galani IE; Cerwenka A; Schirrmacher V; Fournier P
Vaccine; 2011 Feb; 29(6):1185-93. PubMed ID: 21172381
[TBL] [Abstract][Full Text] [Related]
12. IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma.
Lucas ML; Heller R
DNA Cell Biol; 2003 Dec; 22(12):755-63. PubMed ID: 14683586
[TBL] [Abstract][Full Text] [Related]
13. DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.
Cueto FJ; Del Fresno C; Brandi P; Combes AJ; Hernández-García E; Sánchez-Paulete AR; Enamorado M; Bromley CP; Gomez MJ; Conde-Garrosa R; Mañes S; Zelenay S; Melero I; Iborra S; Krummel MF; Sancho D
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33980589
[TBL] [Abstract][Full Text] [Related]
14. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
[TBL] [Abstract][Full Text] [Related]
15. Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
Yamanaka R; Xanthopoulos KG
DNA Cell Biol; 2005 May; 24(5):317-24. PubMed ID: 15869409
[TBL] [Abstract][Full Text] [Related]
16. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.
Peng XC; Yang L; Yang LP; Mao YQ; Yang HS; Liu JY; Zhang DM; Chen LJ; Wei YQ
J Exp Clin Cancer Res; 2008 Sep; 27(1):46. PubMed ID: 18816410
[TBL] [Abstract][Full Text] [Related]
17. Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agent.
Sabbieti MG; Agas D; Capitani M; Marchetti L; Concetti A; Vullo C; Catone G; Gabai V; Shifrin V; Sherman MY; Shneider A; Venanzi FM
Oncotarget; 2015 Feb; 6(6):3590-9. PubMed ID: 25668818
[TBL] [Abstract][Full Text] [Related]
18. Effect of electrically mediated intratumor and intramuscular delivery of a plasmid encoding IFN alpha on visible B16 mouse melanomas.
Heller LC; Ingram SF; Lucas ML; Gilbert RA; Heller R
Technol Cancer Res Treat; 2002 Jun; 1(3):205-9. PubMed ID: 12622513
[TBL] [Abstract][Full Text] [Related]
19. Replicase-based plasmid DNA shows anti-tumor activity.
Rodriguez BL; Yu Z; Chung WG; Weiss R; Cui Z
BMC Cancer; 2011 Mar; 11():110. PubMed ID: 21443770
[TBL] [Abstract][Full Text] [Related]
20. USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.
Hong B; Li H; Lu Y; Zhang M; Zheng Y; Qian J; Yi Q
Mol Cancer; 2014 May; 13():132. PubMed ID: 24884733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
